average weight loss with glp-1 agonists receptor for reduction in people living obesity but without diabetes: a living benefit–harm modelling study GLP-1 Survey: 37.5% of People
Description
Lifestyle Modification for Obesity
It facilitates and improves the use of both ingested nutritional calories and stored energy, accelerating fat-burning and controlling hunger
Cochrane Database Syst Rev 2019;12:Cd013505
Hypersensitivity reactions have been linked with all DPP4i [166]
It is now licensed for use in T2D and for weight management
